Roger D. Tung
2016
In 2016, Roger D. Tung earned a total compensation of $2.6M as President and Chief Executive Officer at Concert Pharmaceuticals, a 272% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $199,962 |
|---|---|
| Option Awards | $1,937,609 |
| Salary | $499,905 |
| Other | $9,756 |
| Total | $2,647,232 |
Tung received $1.9M in option awards, accounting for 73% of the total pay in 2016.
Tung also received $200K in non-equity incentive plan, $499.9K in salary and $9.8K in other compensation.
Rankings
In 2016, Roger D. Tung's compensation ranked 3,683rd out of 14,075 executives tracked by ExecPay. In other words, Tung earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,683 out of 14,075 | 74th |
Division Manufacturing | 1,288 out of 5,489 | 77th |
Major group Chemicals And Allied Products | 399 out of 1,895 | 79th |
Industry group Drugs | 292 out of 1,538 | 81st |
Industry Pharmaceutical Preparations | 229 out of 1,176 | 81st |
Source: SEC filing on April 26, 2017.
Tung's colleagues
We found two more compensation records of executives who worked with Roger D. Tung at Concert Pharmaceuticals in 2016.
News
Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
April 26, 2022
Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
April 27, 2021
Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
April 28, 2020
Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
April 29, 2019